|
Market Closed -
Nasdaq
00:00:00 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1989 USD | +3.59% |
|
-11.21% | -80.11% |
| 10-17 | Tscan Therapeutics, Inc. Announces Board and Committee Changes, Effective October 13, 2026 | CI |
| 10-01 | TScan Therapeutics, Inc. Announces Departure of Chrystal Louis as Chief Medical Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Bio Therapeutic Drugs | +3.59% | -11.21% | -80.11% | -90.66% | -97.80% | 13.01M |  | | |
- Stock Market
- Stocks
- TCRX Stock
- Charts TScan Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
